Avian Coccidiosis in Broilers: Anticoccidial Resistance and Molecular Typing

Abstract

Avian coccidiosis remains a primary constraint on global broiler production efficiency. The disease is caused by apicomplexan parasites of the genus Eimeria, with Eimeria tenella, Eimeria acervulina, and Eimeria maxima representing the most pathogenic and economically significant species. This review synthesizes current knowledge on anticoccidial resistance evolution, molecular typing methodologies for species identification and population genetics, and the strategic deployment of live vaccines. Emphasis is placed on the biophysical mechanisms of drug resistance, the application of polymerase chain reaction (PCR) based diagnostics for resistance monitoring, and the immunological basis of vaccine-induced protection.

1. Introduction and Etiology

Coccidiosis in chickens (Gallus gallus domesticus) is an enteric disease caused by seven recognized Eimeria species: E. tenella, E. acervulina, E. maxima, E. necatrix, E. brunetti, E. mitis, and E. praecox. The disease manifests as malabsorption, hemorrhagic enteritis, and mortality, resulting in substantial economic losses attributed to reduced weight gain, impaired feed conversion ratios, and costs associated with prophylaxis and therapy. The three species E. tenella, E. acervulina, and E. maxima are consistently identified as the most prevalent and virulent in intensive broiler operations [1, 2].

The parasite lifecycle is monoxenous and involves both asexual (schizogony) and sexual (gametogony) phases within the intestinal epithelium. Sporulated oocysts ingested from the environment release sporozoites in the gizzard and upper small intestine. Sporozoites invade enterocytes, initiating schizogony. Merozoites released from schizonts invade new cells, repeating the cycle two to four times depending on the species. Ultimately, merozoites differentiate into macro- and microgametes, fuse to form zygotes, and develop into unsporulated oocysts excreted in feces. Sporulation occurs in the environment under favorable temperature and humidity conditions, completing the cycle.

2. Species-Specific Pathobiology

2.1 Eimeria tenella

E. tenella infects the cecal epithelium. The parasite exhibits a predilection for the crypts of Lieberkuhn during early schizogony, migrating to the villi during later stages. The second and third generation schizonts cause extensive mucosal destruction, hemorrhage, and cecal core formation. The prepatent period is approximately 120 hours. Pathogenicity is driven by massive epithelial turnover and disruption of the cecal microbiome, facilitating secondary bacterial translocation [3, 4].

2.2 Eimeria acervulina

E. acervulina colonizes the duodenum and upper jejunum. It is characterized by numerous small, white plaques visible grossly on the serosal surface. The parasite develops within the villus epithelium, causing villus atrophy, crypt hyperplasia, and severe malabsorption of lipids and fat-soluble vitamins. The prepatent period is the shortest among pathogenic species at approximately 96 hours. High infection intensity correlates with significant reductions in weight gain and feed efficiency [5, 6].

2.3 Eimeria maxima

E. maxima infects the mid-intestine (jejunum and ileum). It produces the largest schizonts of the avian Eimeria species. The parasite induces profound mucosal thickening, petechial hemorrhage, and ballooning of the intestinal wall. E. maxima is the primary predisposing factor for necrotic enteritis caused by Clostridium perfringens due to extensive mucosal damage and plasma protein leakage into the lumen, providing a growth substrate for the bacterium [7, 8].

3. Anticoccidial Resistance: Mechanisms and Epidemiology

3.1 Classification of Anticoccidials

Anticoccidial compounds are broadly classified into ionophores and synthetic (chemical) agents. Ionophores (polyether antibiotics) function as mobile ion carriers, disrupting transmembrane electrochemical gradients in the parasite. Synthetic agents target specific metabolic pathways.

3.2 Molecular Mechanisms of Resistance

Resistance to ionopheres is typically polygenic, involving reduced drug uptake, enhanced efflux, or modification of target membrane lipids. Resistance to synthetic agents frequently involves single nucleotide polymorphisms (SNPs) in target genes. For example, resistance to decoquinate is associated with mutations in the cytochrome b gene (mitochondrial complex III). Resistance to diclazuril and toltrazuril involves mutations in the Eimeria apicoplast genome or nuclear-encoded targets involved in pyrimidine synthesis [2, 9].

A study of Eimeria isolates from Thai broiler farms utilizing shuttle programs (rotation of ionophores and chemicals) demonstrated widespread reduced sensitivity to multiple drug classes. The shuttle strategy, while delaying resistance compared to continuous monotherapy, selected for multi-drug resistant phenotypes over successive production cycles [2].

3.3 Resistance Monitoring

Traditional resistance assessment relies on the Anticoccidial Sensitivity Test (AST), involving controlled challenge of birds with field isolates followed by lesion scoring and oocyst output quantification. This method is labor-intensive, requires specific pathogen-free birds, and lacks throughput. Molecular markers for resistance are under development. Candidate markers include SNPs in the cytochrome b gene for decoquinate resistance and mutations in the EtMic2 (microneme protein 2) gene potentially linked to ionophore tolerance. Quantitative PCR (qPCR) assays targeting these loci allow rapid screening of field populations for resistance allele frequencies [2, 9].

4. Molecular Typing and Species Identification

4.1 PCR-Based Species Identification

Morphometric identification of oocysts is unreliable due to overlapping size ranges and phenotypic plasticity. PCR-based methods targeting species-specific genomic loci are the gold standard for diagnosis and surveillance.

4.1.1 Target Loci

Common targets include:

• Internal Transcribed Spacer (ITS) regions: ITS-1 and ITS-2 of the ribosomal RNA operon. High copy number enhances sensitivity. Species-specific primers amplify distinct fragment sizes.
• Mitochondrial Cytochrome Oxidase Subunit I (COI): Standard barcoding locus. Useful for phylogenetic analysis and detection of cryptic species.
• Single-Copy Nuclear Genes: SCAR (Sequence Characterized Amplified Region) markers, Mic2, SOAP (sporozoite surface antigen). Provide higher specificity for strain differentiation.

4.1.2 Assay Formats

• Conventional PCR: End-point detection via agarose gel electrophoresis. Cost-effective for low-throughput labs.
• Multiplex PCR: Simultaneous amplification of multiple species targets in a single reaction. Reduces reagent consumption and turnaround time.
• Quantitative Real-Time PCR (qPCR): SYBR Green or probe-based (TaqMan) detection. Enables quantification of parasite load (oocyst equivalents per gram of feces) and melting curve analysis for species discrimination.
• Droplet Digital PCR (ddPCR): Absolute quantification without standard curves. Superior precision for low-abundance targets and resistance allele frequency determination.

4.2 Population Genetics and Molecular Epidemiology

Beyond species identification, molecular typing resolves population structure, transmission dynamics, and vaccine strain discrimination.

4.2.1 Microsatellite Markers

Polymorphic microsatellite loci (simple sequence repeats) distributed across the genome provide high-resolution genotyping. Panels of 10-15 loci enable discrimination of clonal lineages, detection of recombination events, and tracking of vaccine vs. field strain spread.

4.2.2 Amplicon-Based Deep Sequencing

Targeted amplicon sequencing of polymorphic loci (e.g., Mic2, AMA1 - apical membrane antigen 1) on high-throughput sequencers generates deep coverage data. This allows detection of minor variants within mixed infections and estimation of allele frequencies for resistance markers.

4.2.3 Whole Genome Sequencing (WGS)

WGS of Eimeria isolates provides the ultimate resolution for outbreak investigation, recombination mapping, and identification of novel resistance mutations. Reference genomes for E. tenella, E. acervulina, and E. maxima facilitate read mapping and variant calling. Bioinformatic pipelines for variant annotation and phylogenetic reconstruction are essential components of modern surveillance programs.

5. Vaccination Strategies

5.1 Live Vaccines: Composition and Attenuation

Live anticoccidial vaccines contain sporulated oocysts of multiple Eimeria species. Two main attenuation strategies are employed:

1. Precociousness (Premature Development): Selection for strains with a shortened prepatent period (reduced number of asexual generations). This reduces intestinal damage while maintaining immunogenicity. Examples: E. tenella HP, E. acervulina HP, E. maxima HP lines.
2. Chemical Attenuation / Passage: Historical method involving passage in the presence of sub-therapeutic anticoccidial levels. Largely superseded by precocious lines due to stability concerns.

Vaccines are administered via spray cabinet at day-old, in-ovo injection at 18 days of embryonation, or via drinking water/feed in the first week of life. Uniform ingestion of a minimum infective dose (MID) by all chicks is critical for synchronous immunity development [10, 11].

5.2 Immunological Basis of Protection

Protective immunity is species-specific and mediated primarily by cell-mediated immune (CMI) responses. CD4+ and CD8+ T lymphocytes, particularly intraepithelial lymphocytes (IELs), are central. Key cytokines include Interferon-gamma (IFN-γ) and Interleukin-2 (IL-2). Antibodies play a minor role, though IgA at the mucosal surface may limit sporozoite invasion. Vaccination induces a controlled primary infection, stimulating memory T-cell populations that rapidly expand upon field challenge, limiting parasite replication [10, 3].

5.3 Vaccine Application Programs

A review of global strategies highlights the increasing adoption of bioshuttle programs in high-density production systems to balance performance and resistance management [10].

5.4 Vaccine Strain Discrimination

Differentiation of vaccine strains from wild-type field strains is essential for monitoring vaccine take, spread, and persistence. Molecular markers include:

• Precocious Line Markers: SNPs or indels in genes associated with the precocious phenotype (e.g., EtHP1 in E. tenella).
• Microsatellite Profiles: Distinct allele sizes at multiple loci.
• qPCR Assays: Allele-specific probes targeting vaccine-specific SNPs.

6. Alternative and Adjunctive Control Measures

6.1 Phytogenics and Natural Products

Numerous plant-derived compounds exhibit anticoccidial activity. Mechanisms include direct parasiticidal effects, immunomodulation, antioxidant activity, and microbiome modulation.

• Curcumin: Modulates gut bacterial populations and the NF-κB/NRF2 immune-redox axis. Studies in broilers challenged with mixed Eimeria species demonstrate improved growth performance, reduced lesion scores, decreased oocyst shedding, and enhanced intestinal barrier integrity when curcumin is supplemented in diets containing soybean or canola oil [1, 5].
• Lavender Essential Oil (Lavandula angustifolia): First reported in vitro and in vivo efficacy against E. tenella from plants grown in the Kashmir Himalayas. Mechanisms involve disruption of parasite membrane integrity and modulation of host oxidative stress pathways [12].
• Gentiana scabra: Mitigates E. tenella-induced coccidiosis by regulating the gut microbiota-metabolome axis and strengthening the intestinal barrier [4].
• Quercetin and Thyme Oil: Modulate oxidative stress biomarkers and mRNA expression of interleukins (IL-6, IL-2, IL-16) during E. tenella infection [3].
• 5-Aminolevulinic Acid (5-ALA): Suppresses body weight loss and reduces disease severity during E. tenella infection [13].
• Red Osier Dogwood Extract: Improves growth performance, protein digestibility, tibia breaking strength, immune response, and gut health in a coccidiosis vaccine challenge model [14].

6.2 Probiotics and Direct-Fed Microbials

Administration of Lactobacillus acidophilus and Enterococcus faecium via in-ovo or drinking water routes enhances resistance to Eimeria infection. Mechanisms include competitive exclusion, bacteriocin production, modulation of mucosal immunity (increased IgA, cytokine profiles), and maintenance of intestinal barrier function [11].

6.3 Bacteriophage Therapy

Bacteriophages targeting Clostridium perfringens have been combined with black cumin seeds to mitigate necrotic enteritis, a common sequel to E. maxima infection. This approach addresses the bacterial component of the enteric disease complex [7].

7. Diagnostic Workflow and Decision Support

The following diagram illustrates a comprehensive diagnostic and decision-making workflow for coccidiosis management in broiler operations.

flowchart TD
    A[Clinical Suspicion: Reduced Performance, Mortality, Wet Litter], > B{Necropsy & Lesion Scoring<br/>Johnson & Reid Scale}
    B, > C[Sample Collection: Feces, Intestinal Scrapings, Cecal Contents]
    C, > D[Oocyst Quantification: McMaster Technique OPG]
    C, > E[Molecular Diagnostics: DNA Extraction]
    E, > F{PCR Panel}
    F, >|Species ID| G[Multiplex qPCR: ITS-1/COI Targets<br/>E. tenella, E. acervulina, E. maxima, etc.]
    F, >|Resistance Screening| H[Allele-Specific qPCR / ddPCR<br/>Cytochrome b SNPs, Mic2 Variants]
    F, >|Vaccine Discrimination| I[Strain-Specific qPCR / Amplicon Seq<br/>Precocious Markers, Microsatellites]
    G, > J[Species Composition & Parasite Load]
    H, > K[Resistance Allele Frequency Report]
    I, > L[Vaccine Take & Field Strain Pressure]
    J & K & L, > M[Integrated Decision Support]
    M, > N{Management Decision}
    N, >|High Pathogenic Load<br/>Sensitive Isolates| O[Targeted Anticoccidial Treatment<br/>Shuttle/Rotation Program]
    N, >|Multi-Drug Resistance<br/>High Field Pressure| P[Live Vaccine Introduction<br/>Bioshuttle or Full Rotation]
    N, >|Vaccine Breakthrough| Q[Adjunctive Therapy: Phytogenics,<br/>Probiotics, 5-ALA]
    N, >|Necrotic Enteritis Risk| R[Clostridium perfringens PCR/Toxinotyping<br/>Bacteriophage/Phytogenic Intervention]
    O & P & Q & R, > S[Post-Intervention Monitoring: OPG, Lesion Scores, Performance Metrics]
    S, > A

8. Co-Infections and Disease Complexes

Coccidiosis rarely occurs in isolation. The disrupted intestinal epithelium and altered microbiome create permissive conditions for secondary pathogens.

• Necrotic Enteritis (NE): Clostridium perfringens type A (NetB toxin positive) proliferation is strongly associated with preceding E. maxima infection. Plasma proteins in the lumen serve as growth factors. Subclinical coccidiosis is a major predisposing factor for subclinical NE, impacting performance without overt mortality [7, 8].
• Avian Pathogenic Escherichia coli (APEC): Mucosal damage facilitates translocation of APEC, leading to colibacillosis, airsacculitis, and systemic infection.
• Viral Enteritis: Co-infections with avian astroviruses, rotaviruses, or reoviruses exacerbate malabsorption. Avian influenza co-infection has been documented in broiler farms, complicating diagnosis and control [15].

9. Biomarkers for Non-Invasive Monitoring

Fecal biomarkers offer potential for flock-level monitoring without necropsy. Acute-phase proteins (APPs) such as ovotransferrin, serum amyloid A, and alpha-1-acid glycoprotein are elevated in feces during necrotic enteritis and coccidiosis. Quantification via ELISA or targeted proteomics provides a dynamic measure of intestinal inflammation severity and treatment response [8].

10. Environmental Factors and Housing

Experimental housing methods (floor pens vs. battery cages) and management practices (feed withdrawal prior to challenge) influence the temporal dynamics of infection and the expression of dietary additive effects. Floor pen systems better simulate commercial litter recycling and oocyst sporulation dynamics, affecting the reproducibility of challenge models [6].

11. Future Directions

1. CRISPR-Based Diagnostics: Adaptation of CRISPR-Cas systems (e.g., SHERLOCK, DETECTR) for rapid, isothermal, point-of-care detection of Eimeria species and resistance markers.
2. Transcriptomic Signatures: Host gene expression profiling in intestinal tissue or peripheral blood to define immune correlates of protection and predict vaccine efficacy.
3. Population Genomics: Large-scale WGS of global Eimeria collections to define the pangenome, track the spread of resistance haplotypes, and inform vaccine strain updates.
4. Next-Generation Vaccines: Subunit vaccines based on recombinant antigens (e.g., AMA1, IMP1, SO7) delivered via viral vectors or nanoparticle platforms to eliminate the variability and biosafety concerns of live vaccines.
5. Precision Nutrition: Integration of real-time diagnostic data with feed formulation algorithms to dynamically adjust phytogenic and probiotic inclusion rates based on flock infection status.

12. Conclusion

Effective control of avian coccidiosis in broilers requires an integrated approach combining molecular diagnostics for species identification and resistance monitoring, strategic deployment of live vaccines within rotation or bioshuttle programs, and the judicious use of alternative additives targeting parasite biology and host resilience. The transition from empirical chemotherapy to diagnostics-driven, resistance-informed management is essential for sustainable poultry production. Continued advancement in high-resolution molecular typing and the development of non-invasive biomarkers will enhance the precision and proactivity of coccidiosis control programs.

References

[1] Abdulhusein HM, Taherpour K, Ghasemi HA et al. Curcumin modulates targeted gut bacterial populations and NF-κB/NRF2 immune-redox responses in Eimeria-challenged broilers fed soybean or canola oil. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42252365/

[2] Tongkamsai S, Boobphahom S, Apphaicha R et al. Anticoccidial Resistance in Eimeria spp. From Thai Broiler Farms Using Shuttle Programs. Vet Med Int. 2026. https://pubmed.ncbi.nlm.nih.gov/42180163/

[3] Mohamed RA, Ali HA, Salem GA et al. Assessment of Quercetin and Thyme Oil Effect on Oxidative Stress Biomarkers and mRNA Expressions of Interleukin 6, 2, and 16 During Eimeria tenella Infection. Avian Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41973004/

[4] Yuke Z, Chen X, Abuzeid AMI et al. Gentiana scabra mitigates Eimeria tenella-induced Coccidiosis by regulating the gut microbiota-metabolome and strengthening the intestinal barrier. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41936291/

[5] Abdulhusein HM, Taherpour K, Ghasemi HA et al. Curcumin-mediated resilience to mixed Eimeria challenge in broilers fed soybean or canola oil: growth performance, hematology, coccidial lesions, oocyst shedding, digestibility, and intestinal barrier biology. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42096901/

[6] Froebel LE, Watson BY, Rincker MJ et al. Temporal effects of a botanical feed additive and experimental housing methods in broilers exposed to an acute feed withdrawal period prior to coccidiosis inoculation. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42019473/

[7] Manjunaha V, Justice-Alucho CH, Lumpkins BS et al. Combined effect of black cumin seeds and bacteriophage in mitigating necrotic enteritis in broiler chickens. J Appl Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42202769/

[8] Mahmoud MA, Buiatte V, Baumrucker CR et al. Investigating Acute-Phase Proteins in Feces of Broiler Chickens Undergoing Necrotic Enteritis: A Potential Tool for Assessment and Monitoring. Avian Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41973007/

[9] Pham HSH, Nguyen TH, Le DP et al. Evaluation of the therapeutic efficacy of the sulfamidine-diaveridine combination against Vietnamese field isolate of Eimeria spp. in broiler chickens. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41962192/

[10] Pages M, Dardi M. Live anticoccidial vaccines in the poultry industry: current knowledge, global strategies, technical foundations and future directions. Avian Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/42159705/

[11] Aydin R, Tegün E, Özüiçli M et al. Efficacy of in ovo and drinking water delivery of Lactobacillus acidophilus and Enterococcus faecium against Eimeria infection in broiler chickens. Exp Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42092525/

[12] Iqbal S, Tanveer S, Allaqaband SM et al. Lavender essential oil as a novel anticoccidial agent: First report from in-vitro and in-vivo studies of Lavandula angustifolia flowering plant grown in the Kashmir Himalayas. Microb Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/42061661/

[13] Hanif TA, Matsubayashi M, Hatabu T. Supplementation of 5-Aminolevulinic Acid Suppressed Body Weight Loss and Reduced Disease Severity During Eimeria tenella Infection in Broiler Chickens. J Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42028132/

[14] Santos Reis Pereira I, I Adewole D. Effects of red osier dogwood extract on growth performance, protein digestibility, tibia breaking strength, immune response, and gut health of broiler chickens in a coccidiosis vaccine challenge model. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42105386/

[15] Hartady T, Sugandi SD, Viqih M. A Case of Avian Influenza Co-Infection and Multifactorial Diseases in a Broiler Chicken Farm in Majalengka, West Java, Indonesia. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42076736/